These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33038875)

  • 1. Relationship between bone turnover markers and oxidative stress in children with type 1 diabetes mellitus.
    El Amrousy D; El-Afify D; Shabana A
    Pediatr Res; 2021 Mar; 89(4):878-881. PubMed ID: 33038875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus.
    Pácal L; Varvařovská J; Rušavý Z; Lacigová S; Stětina R; Racek J; Pomahačová R; Tanhäuserová V; Kaňková K
    Arch Physiol Biochem; 2011 Oct; 117(4):222-30. PubMed ID: 21338322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents.
    Choi JS; Park I; Lee SJ; Ju HJ; Lee H; Kim J
    Yonsei Med J; 2019 Dec; 60(12):1174-1180. PubMed ID: 31769248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover markers in children and adolescents with type 1 diabetes-A systematic review.
    Madsen JOB; Jørgensen NR; Pociot F; Johannesen J
    Pediatr Diabetes; 2019 Aug; 20(5):510-522. PubMed ID: 30941847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased markers of bone turnover in children and adolescents with type 1 diabetes.
    Madsen JOB; Herskin CW; Zerahn B; Jørgensen NR; Olsen BS; Pociot F; Johannesen J
    Pediatr Diabetes; 2020 May; 21(3):505-514. PubMed ID: 31970841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
    Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
    J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers of bone turnover in girls during puberty.
    Blumsohn A; Hannon RA; Wrate R; Barton J; al-Dehaimi AW; Colwell A; Eastell R
    Clin Endocrinol (Oxf); 1994 May; 40(5):663-70. PubMed ID: 7516828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes mellitus: Complex interplay of oxidative stress, cytokines, gastrointestinal motility and small intestinal bacterial overgrowth.
    Malik A; Morya RK; Bhadada SK; Rana S
    Eur J Clin Invest; 2018 Nov; 48(11):e13021. PubMed ID: 30155878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover markers are differentially affected by pre-analytical handling.
    Christensen GL; Halgreen JR; Milenkovski M; Köse A; Quardon N; Jørgensen NR
    Osteoporos Int; 2019 May; 30(5):1137-1141. PubMed ID: 30680430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus.
    Zhao C; Liu G; Zhang Y; Xu G; Yi X; Liang J; Yang Y; Liang J; Ma C; Ye Y; Yu M; Qu X
    J Clin Lab Anal; 2020 Apr; 34(4):e23112. PubMed ID: 31733013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
    Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
    Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of carbohydrate counting in glycemic control and oxidative stress in patients with type 1 diabetes mellitus (T1DM).
    Kostopoulou E; Livada I; Partsalaki I; Lamari F; Skiadopoulos S; Rojas Gil AP; Spiliotis BE
    Hormones (Athens); 2020 Sep; 19(3):433-438. PubMed ID: 32221838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The L-arginine/NO pathway, homoarginine, and nitrite-dependent renal carbonic anhydrase activity in young people with type 1 diabetes mellitus.
    Carmann C; Lilienthal E; Weigt-Usinger K; Schmidt-Choudhury A; Hörster I; Kayacelebi AA; Beckmann B; Chobanyan-Jürgens K; Tsikas D; Lücke T
    Amino Acids; 2015 Sep; 47(9):1865-74. PubMed ID: 26123986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover: an update.
    van Daele PL; Birkenhäger JC; Pols HA
    Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials.
    Taku K; Melby MK; Kurzer MS; Mizuno S; Watanabe S; Ishimi Y
    Bone; 2010 Aug; 47(2):413-23. PubMed ID: 20452475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation Between Oxidative Stress and Hematologic Abnormalities in Children With Type 1 Diabetes.
    Abdel-Moneim A; Zanaty MI; El-Sayed A; Khalil RG; Rahman HA
    Can J Diabetes; 2020 Apr; 44(3):222-228. PubMed ID: 31630989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone turnover marker reference intervals in young females.
    Callegari ET; Gorelik A; Garland SM; Chiang CY; Wark JD
    Ann Clin Biochem; 2017 Jul; 54(4):438-447. PubMed ID: 27496795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.